Advanced Filters
noise

Lung Disease Clinical Trials

A listing of Lung Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 3,189 clinical trials
D Dan Yao The First Affiliated Hospital of Wenzhou Medical University, Master

Anlotinib Capsules in the Treatment for IPF/PF-ILDs

The use of Anlotinib hydrochloride capsules for the treatment of IPF/PF-ILDs, with FVC as the primary efficacy endpoint to evaluate its effectivenes

40 - 85 years of age All Phase 2/3
S Su Ying Low, BMBCh

Prospective Data Collection of Patients With Diffuse Parenchymal Lung Diseases

The purpose of this study is to generate a prospective database of all patients evaluated for diffuse parenchymal lung diseases to provide much needed data on the various disease aetiologies, incidence and prevalence rates, clinical and radiological presentations, pathologic correlations, disease progression and response to treatment, and final outcomes in …

21 - 90 years of age All Phase N/A
S Sharon Maxwell, Bachelor of Nursing

Treatable Traits in Interstitial Lung Disease

The goal of this clinical trial is to learn if a personalised treatment model of care "treatable traits" can improve quality of life and disease progression in patients with interstitial lung disease. The main question it aims to answer is, will providing a treatable traits model of care improve health-related …

18 years of age All Phase N/A
A Anna Palmisano Professor Anna Palmisano

Advanced Mutidimensional and Ultra High Resolution Computed Tomography to Inspect Cardiopulmonary Involvement in Progressive Fibrosing Interstitial Lung Diseases

Interstitial lung diseases (ILDs) are common chronic disease characterized by high mortality and morbidity, also linked to cardiovascular implication. Cardiovascular complications, occur early in idiopathic pulmonary fibrosis (IPF) and other ILDs without anysymptoms. Symptoms are often misinterpreted and diagnosis delayed to irreversible stages of cardiac dysfunction. Mechanism of cardiac damage, …

18 years of age All Phase N/A
A Alda S. Marques, PhD

LetS Get fUnctional! FuNctional Status in pEople With intersTitial Lung Disease

This study aims to i) To characterize the functional status and explore the determinants of functional status decline of people with IlD ii)To determine the measurement properties of functional status instruments in people with Interstitial lung diseases (ILD) iii) To identify the impact of ILD and the participants' perspectives on …

18 years of age All Phase N/A
C Carley Stewart, PhD

Functional MRI for Monitoring Progression and Assessing Trends in ILD

The main objective of this study is to investigate the utility of functional MRI to differentiate, characterize, and monitor subgroups of ILD. This can be broken down into three specific objectives: Determine if ILD features observed on high-resolution computed tomography (HRCT), such as ground glass opacities (GGO), are functionally different. …

18 years of age All Phase N/A
G Gabor Kovacs, MD

Database for Interstitial Lung Disease

The purpose of this study is to establish a clinical database for patients bearing at risk for ILD (Interstitial Lung Disease) and to set up a prospective ILD Screening program for these patients.

18 years of age All Phase N/A
L Ling Li Qian, Doctor

Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes

The aim of this proposed study is to evaluate the efficacy and safety of hydroxychloroquine (HCQ) in children's interstitial lung diseases(chILD) with genetic causes. This study is a randomized controlled clinical trial.

1 - 18 years of age All Phase 0
U Ulrich Matt, MD, PhD

Sequelae of Sars-CoV-2 Infections

By the end of 2019 a new coronavirus, named SARS-CoV-2, was discovered in patients with pneumonia in Wuhan, China. In the following weeks and months the virus spread globally, having a tremendous impact on global health and economy. To date, no vaccine or therapy is available. Severe courses of the …

18 years of age All Phase N/A
C Carrie Stevens

Regional Monitoring of CF Lung Disease

The main reason for this research study is to learn more about some new tests that are being developing for patients with Cystic Fibrosis (CF) to measure changes in the lungs. In this study, the focus will be to learn how stopping Airway Clearance (ACT) and re-starting ACT can affect …

12 - 21 years of age All Phase 0

Simplify language using AI